Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Gains from Sales and Divestitures (2011 - 2015)

National Healthcare posted quarterly Gains from Sales and Divestitures of $6000.0 for Q4 2015, little changed year-on-year from $6000.0 in Q4 2014, and little changed on a QoQ basis from $6000.0 in Q3 2015.

National Healthcare (NHC) has 5 years of Gains from Sales and Divestitures data on file, last reported at $6000.0 in Q4 2015.

  • For the quarter ending Q4 2015, Gains from Sales and Divestitures changed 0.0% year-over-year to $6000.0; the trailing twelve-month figure through Dec 2015 stood at $6000.0 (changed 0.0% YoY), and the FY2015 full-year result was $6000.0, changed 0.0% from the prior year.
  • Gains from Sales and Divestitures for Q4 2015 stood at $6000.0, roughly flat from $6000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $6000.0 in Q4 2011 and bottomed at -$6000.0 in Q2 2012.
  • The 5-year median for Gains from Sales and Divestitures is $6000.0 (2011), against an average of $4153.8.
  • The widest annual swing landed in 2012, when Gains from Sales and Divestitures changed 0.0%; it then surged 200.0% in 2013.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $6000.0 in 2011, then changed by 0.0% to $6000.0 in 2012, then changed by 0.0% to $6000.0 in 2013, then changed by 0.0% to $6000.0 in 2014, then changed by 0.0% to $6000.0 in 2015.
  • The last three Gains from Sales and Divestitures figures came in at $6000.0 (Q4 2015), $6000.0 (Q3 2015), and $6000.0 (Q2 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 National Healthcare 2.87 Bn 2.61 Bn 290.58 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2015 6,000.00
Dec 31, 2015 6,000.00
Sep 30, 2015 6,000.00
Sep 30, 2015 6,000.00
Jun 30, 2015 6,000.00
Jun 30, 2015 6,000.00
Dec 31, 2014 6,000.00
Dec 31, 2014 6,000.00
Sep 30, 2014 6,000.00
Sep 30, 2014 6,000.00
Jun 30, 2014 6,000.00
Jun 30, 2014 6,000.00
Dec 31, 2013 6,000.00
Dec 31, 2013 6,000.00
Sep 30, 2013 6,000.00
Sep 30, 2013 6,000.00
Jun 30, 2013 6,000.00
Jun 30, 2013 6,000.00
Dec 31, 2012 6,000.00
Dec 31, 2012 6,000.00
Sep 30, 2012 -6,000.00
Sep 30, 2012 -6,000.00
Jun 30, 2012 -6,000.00
Jun 30, 2012 -6,000.00
Dec 31, 2011 6,000.00
Dec 31, 2011 6,000.00